Great Point Partners LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Great Point Partners LLC
- $121 Million
- Q2 2025
A detailed history of Great Point Partners LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 323,170 shares of KALV stock, worth $3.83 Million. This represents 3.03% of its overall portfolio holdings.
Number of Shares
323,170
Previous 1,014,367
68.14%
Holding current value
$3.83 Million
Previous $11.7 Million
68.77%
% of portfolio
3.03%
Previous 7.24%
Shares
11 transactions
Others Institutions Holding KALV
# of Institutions
149Shares Held
54.3MCall Options Held
1.07MPut Options Held
90.1K-
Vr Adviser, LLC New York, NY6.73MShares$79.8 Million15.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.96MShares$58.8 Million1.93% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$58.6 Million3.35% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$58 Million2.92% of portfolio
-
Vestal Point Capital, LP New York, NY4.68MShares$55.4 Million2.78% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $292M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...